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ABSTRACT
Sun Pharmaceutical is a trailblazer in Indian pharmaceutical sector, and one of the foremost competitors in the generic drug market sets its eye on 
Ranbaxy. Sun pharmacy which was established in 1983 listed from 1994 has its upper hand in product development. Ranbaxy was incorporated in 
1973, and Daiichi Sankyo, a Japanese firm, got a controlling share from 2008. This amalgamation between Sun Pharmacy and Ranbaxy would get 
profitable transaction for the former. The process of the coalition was a cloak and dagger affair until April 6, 2014. Before mergers and acquisitions, 
a company has to create an urgency call among the employees which will result in better understanding of the whole scenario. The aspects are about 
how financial motives and non-financial motives play a major role in mergers. This case deals with the human resource issues and complexities faced 
by  the two players in the same business.
Keywords: Merger, Acquisition, Change management, Human resource, Employee engagement, Corporate strategy.
INTRODUCTION
The combination of Sun Pharmaceutical Company and Ranbaxy 
was expected to form the fifth largest drug-creating company within 
the world and therefore the largest India. Post merger, if Ranbaxy 
disappears from its current operations then the combined entity will 
extend upto 55 countries with 47 producing facilities. Daiichi Sankyo 
Inc., the previous owner of Ranbaxy, became the second largest investor 
in Sun Pharmaceutical Company and was to possess one representative 
on the company’s board of administrators [1].
In today’s competitive environment, there is a continuous effort by 
organizations to reduce cost and increase efficiency. One critical factor 
that organizations tend to ignore is investing in human capital. Sun 
Pharmacy realized that improving the skill and knowledge of employees 
can help them attain great cost reductions. The most successful 
organizations are able to build high-performance workforce. There 
is a definite link between employee engagement and organizational 
performance. If the management is able to identify and remove 
the roadblocks that decrease engagement, they can ensure better 
performance of both individual and organization [2].
Different parts of meeting up for a shared objective or a reason will 
result in high performance. This has been a repeating highlight for the 
worldwide pharmaceutical industry too. As weights on medication 
assembling, innovative work, and administrative perspectives have 
been on the ascent in view of the aggressive business environment in the 
most recent decade, the pharmaceutical business’ overall development 
has achieved an immersion point [3].
Streets for development have got to be restricted as a result of declining 
remedies of marked medications and appearance of nonexclusive 
medication items. Further administrations of North America and 
Europe are compelled to press their social insurance spending plans to 
the bigger masses with financially savvy bland items.
CASE ANALYSIS
Marked medication results of the bigger pharmaceutical organizations 
face cost increments to conceal for the declining edges. Every one of 
these elements adds to the rising merger and procurement marvel in 














Examiners trust that merger and acquisitions are not ready to make 
the worth as coveted for the blended association as they are seen as 
wellspring of interruption for the continuous innovative work programs 
and in addition to other basic activities. In any case, the general 
advantages of the merger and securing methodology supersedes the 
disturbances. As indicated by the investigators, the mergers are basic 
for the long-term advantages of the pharmaceutical business and for 
their short and long haul survival. The worldwide pharmaceutical 
scene resembles a major sea where the bigger fish eats the littler fish 
for its survival. In an indistinguishable way, the biological system of the 
pharmaceutical business acts also.
In fact, the vast majority of the pharmaceutical organizations which 
have stayed in the Top 20 around 1995 and 2005 have been included 
in super mergers. Examiners characterize “super mergers” as 
arrangement esteem and size intersection $ 10 billion. The genuine 
effect of mergers can be broke down from the years 1995 to 2011 
where all arrangement size more prominent than $ 10 billion can be 
considered as the strengths molding the pharmaceutical scene.
The sales chart of Sun Pharma shows that 60% of contribution from 
US and 23% of contribution from India and Ranbaxy’s sales chart 
shows that 29% of share from US and 21% from India which result in 
combined entity of 47% of share from US and 22% from India (Fig. 1).




•	 The	change	management	 steps	are	mainly	 focused	on:	Need	 for	
urgency, forming an effective consortium, creating an action plan, 
communicating the action plan, delegating others to involve, planning 
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HUMAN RESOURCE (HR) ISSUES
Practices and policies
1. Making certain HR practices is must in a profound merger wherever 
we have a tendency to frame to vary each company. It will be useful 
for managers to understand a lot of issues regarding HR areas ought 
to amendment and what conditions contribute to vary them (Fig. 3).
In the systematic and planned merger, it is believed that one firm will 
follow	 the	 practices	 and	 policies	 of	 the	 other.	 This	 could	 appear	 easy;	
nevertheless, there could also be conditions underneath that it is 
inappropriate to vary all practices. As an instance, if one firm acquires 
another in high value proposition there exists a huge and in depth brand 
potential and talent management practices .This will be a strategic choice 
for the company to retain  dynamic policies.Retaining existing dynamic 
policies and practices. The motive of merger are either finance motive or 
non-finance motive (Fig 4).
2. In a design or natural process, merger could have the foremost important 
impact on staff as a result of the amendment is extremely important. 
In general, in the initial juncture of merger, it is assumed that future 
accomplishments of the companies and staff will also be better.
The conditions underneath the deal may fail for the subsequent.
•	 Sun	Company	needs	to	check	the	authority	problems		with	Ranbaxy.	
The US authority has banned four of Ranbaxy’s key plant that might 
last another year 
•	 EBIDTA	of	Ranbaxy	is	extremely	low	around	ten,	means	below	trade	
standards and Sun Company needs to increase the EBIDTA
•	 Sun	Company	needs	to	increase	the	profitableness	in	rising	markets	
like Romanian state wherever Ranbaxy is doing dangerous
•	 There	is	also	a	difficulty	with	the	Competition	Commission	of	Asian	
country as there are nearly 25 medicines which the combined entity 
holds over 400th market share
•	 Ranbaxy	 has	 high	 debt	 on	 its	 record	 and	 Sun	 drug	 company	
has to begin with ways that to cut back the debt going forward. 
ThePharmaceutical deal which costs of 4billion USD will limit sun 
pharma entering into specialty business for quite some time
•	 However,	Sun	Drug	Company	can	have	powerful	task	to	shelve	high	






The Sun Pharmaceutical Company CEO Dilip Sanghvi is good in 
acquiring companies which are in critical situations and flourishes it 
to a different extent. Because of this, Daichii Sankyo is happy in this 
acquisition of Ranbaxy.
Fig. 1: Sales chart
Fig. 2: Framework for change management
Fig. 3: Strategic model of HRM
Fig. 4: Merger topology
EXHIBIT-1
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